India Drug Delivery Devices Market 2024, with Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma

Key Market Trends include Increasing Funding from Government & Private Organization and Innovative Strategies Adopted by The Key Market Players


Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "India Drug Delivery Devices Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.

The India Drug Delivery Devices Market was valued at USD 12.70 Billion in 2024, and is expected to reach USD 18.05 Billion by 2030, rising at a CAGR of 6.11%.

With various segments based on the route of administration, including oral, injectable, topical, ocular, nasal, and pulmonary, this market caters to the specific needs of patients across different medical domains. Technological advancements continue to drive innovation in drug delivery devices, enabling more precise and targeted treatment options for patients. The increased prevalence of chronic diseases and the growing geriatric population are significant factors contributing to the growth of this market.

As the demand for effective and convenient drug delivery solutions continues to rise, the Drug Delivery Devices Market remains a dynamic and evolving sector within the healthcare industry.



Key Market Trends

Increasing Funding from Government & Private Organization

In India, the demand for drug delivery devices has experienced a significant surge in recent years. This surge can be attributed to several factors, including a substantial increase in funding from both government and private organizations. These organizations have recognized the vital role that drug delivery devices play in enhancing the efficiency of drug administration and improving patient outcomes. Government initiatives, such as the National Health Mission (NHM) and Ayushman Bharat, have been instrumental in driving this growth. These initiatives have not only increased their investment in healthcare infrastructure and technologies but have also prioritized the development and acquisition of innovative drug delivery devices. As a result, healthcare providers across the country have witnessed an influx of funding, which has not only bolstered the availability of these devices but has also facilitated extensive research and development efforts.

Private organizations, including large pharmaceutical companies and health-focused NGOs, have also played a significant role in this landscape. These organizations have recognized the importance of investing in advanced drug delivery systems and have allocated substantial resources to support their development and acquisition. This collaborative effort between the public and private sectors has led to the introduction of more advanced and effective delivery systems, meeting the evolving needs of healthcare providers and patients alike. The overall effect of this funding surge is a rapid increase in demand for drug delivery devices in India. As healthcare providers strive to offer the best possible care to their patients, they are increasingly relying on these devices to ensure accurate and efficient drug administration. This growing demand not only reflects the commitment of healthcare providers to deliver optimal care but also highlights the transformative impact that advanced drug delivery devices can have on patient outcomes.

Innovative Strategies Adopted by The Key Market Players

Innovative strategies adopted by key market players in India are significantly driving the demand for drug delivery devices. These companies are not only focusing on research and development, but they are also investing in cutting-edge technologies to introduce new and improved devices. These devices aim to provide effective, safe, and patient-friendly methods of drug delivery.

For instance, the implementation of drug-eluting stents has been transformative in improving patient outcomes in cardiovascular conditions. These stents release medication to the affected area, reducing the risk of complications and enhancing the effectiveness of treatment. Similarly, the rise in insulin pens has revolutionized the management of diabetic conditions. These pens offer a convenient and precise way to administer insulin, improving patient compliance and overall diabetes management.

Collaborations and partnerships have become a prevailing trend in the industry. This has led to enhanced technological exchange and product portfolio expansion. Companies are joining forces to leverage their strengths and resources, resulting in the development of more advanced and diverse drug delivery devices. To ensure accessibility to advanced healthcare, companies are strategically targeting rural areas. They are focusing on providing affordable and user-friendly devices that can be easily used by healthcare professionals in these areas. This effort aims to bridge the healthcare gap between urban and rural regions, making essential treatments more accessible to all.

The introduction of digitized devices and telemedicine services has created a paradigm shift in the industry. These innovations offer remote patient monitoring and adherence tracking, providing real-time data to healthcare providers. This not only improves patient care but also helps in identifying any potential issues or complications early on. These advancements in drug delivery devices have not only heightened patient trust but have also demonstrated treatment efficacy. The expanded market reach has resulted in the growth of drug delivery devices in India, making significant contributions to the healthcare industry and improving the overall quality of patient care.

Regional Insights

Based on region, West India emerged as the dominating region in India Drug Delivery Devices Market in 2024. This dominance can be attributed to the high concentration of reputable pharmaceutical companies, supported by a robust healthcare infrastructure and substantial investments in cutting-edge research and development activities within these states.

The region's strategic geographical location, favorable government policies, and well-established supply chain networks contribute significantly to its prominence in the market. In Maharashtra, for example, the city of Mumbai serves as a key hub for pharmaceutical manufacturing and research, housing numerous renowned pharmaceutical companies and research institutions. The state's well-developed healthcare infrastructure, with top-notch hospitals and medical facilities, ensures a conducive environment for the development and adoption of advanced drug delivery devices.

Gujarat, on the other hand, boasts a strong pharmaceutical presence with a wide range of pharmaceutical companies operating in the state. The government's proactive approach in promoting research and development, along with attractive incentives for pharmaceutical companies, has further bolstered the state's position as a major player in the drug delivery devices market. The Western region's strategic geographical location plays a crucial role in its prominence within the market. Situated on the western coast of India, it provides convenient access to both domestic and international markets, facilitating efficient distribution and export of drug delivery devices. The region benefits from well-established supply chain networks, ensuring smooth and timely delivery of products to healthcare providers and end-users.

Key Market Players

  • Pfizer
  • Novartis India
  • GlaxoSmithKline Pharmaceuticals
  • India Medtronic
  • Cardinal Health International India
  • B. Braun Medical (India)
  • Sun Pharmaceutical Industries
  • 3M India
  • Cipla
  • Bayer Zydus Pharma

Key Attributes:

Report AttributeDetails
No. of Pages80
Forecast Period2024 - 2030
Estimated Market Value (USD) in 2024$12.7 Billion
Forecasted Market Value (USD) by 2030$18.05 Billion
Compound Annual Growth Rate6.1%
Regions CoveredIndia

Report Scope:

In this report, the India Drug Delivery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

India Drug Delivery Devices Market, By Devices:

  • Syringe
  • Inhaler
  • Nebulizer
  • Transdermal Patch

India Drug Delivery Devices Market, By Route of Administration:

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Others

India Drug Delivery Devices Market, By Application:

  • Cancer
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Others

India Drug Delivery Devices Market, By End User:

  • Hospitals
  • Diagnostic Centres
  • Ambulatory Surgery Centres
  • Others

India Drug Delivery Devices Market, By Region:

  • North
  • South
  • West
  • East

For more information about this report visit https://www.researchandmarkets.com/r/kam91s

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Indian Drug Delivery Devices Market

Kontaktdaten